References
- Choo Q L, Kuo G, Weiner A G, Overby L R, Bradley D W, Houghton M. Isolation of a cDNA clone derived from a blood‐borne non‐A non‐B viral hepatitis genome. Science 1989; 244: 359–361
- Kuo G, Choo Q L, Alter H J, Gitnick G L, Redeker A G, Purcell R H, Miyamura T, Dienstag J L, Alter M J, Stevens C E, Tegtmeier G E, Bonino F, Colombo M, Berger K, Shuster J R, Overby R L, Bradley D W, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non‐A non‐B hepatitis. Science 1989; 244: 362–364
- Hofman H. Hepatitis C in Austria. Abstract, 1st International Meeting on hepatitis C virus, Rome, 1989
- Trepo C, Pichoud C, Zoulim F, Rougier P, Causse X, Chossegros P, Chevallier P, Sepetjan M, Vitvitski L. Prevalence of anti HCV in chronic liver diseases in France: correlation with anti HBc. Abstract, 1st International Meeting on hepatitis C virus, Rome, 1989
- Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F. Antibodies to hepatitis C virus. Lancet 1989; 2: 324–325
- Gallo M L, Iaccarino L, Parisio Perrotti G, Vacca C, Gigliotti T, Amitrano L, D'Agostino S, Giannelli E. Prevalence of antibody to hepatitis C virus (anti‐HCV) in cryptogenic chronic liver disease and alcoholic cirrhosis in Naples‐Italy. Abstract, 1st International Meeting on hepatitis C virus, Rome, 1989
- Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi F B. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1989; 1: 258–259
- Sanchez‐Tapias J M, Barrera J M, Costa J, Ercilla L, Bachs L, Comalrrena F, Soley F, Bruix J, Calvet X, Gil M P, Mas A, Bruguera M, Castillo R, Rodes J. Hepatitis C virus infection in non‐alcoholic chronic liver disease. Abstract, 1st International Meeting on hepatitis C virus, Rome, 1989
- Esteban J I, Esteban R, Viladomiu L, López‐Talavera J C, González A, Hernández J M, Roget M, Vargas V, Genesca J, Buti M, Guardia J. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Bruix J, Barrera J M, Calvet X, Ercilla G, Costa J, Sanchez‐Tapias J M, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–1008
- Mortimer P P, Cohen B J, Litton P A, Vandervelde E M, Bassendine M F, Brind A M, Hambling M H. Hepatitis C virus antibody. Lancet 1989; 2: 798
- Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Pregliasco F, Ferroni P, Alberti A. Antibody to hepatitis C virus (anti‐HCV) in community‐aquired non‐A, non‐B hepatitis. Abstract, 1st International Meeting on hepatitis C virus, Rome, 1989
- McFarlane I G, Smith H M, Johnson P J, Bray G P, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or false‐positive result?. Lancet 1990; 1: 754–757
- Schvarcz R, Weiland O, von Sydow M. False positive reactivity for antibodies against hepatitis C virus in patients with autoimmune chronic active hepatitis?. Scand J Infect Dis 1990; 22: 377–378